Bryan Keaney

Chief Financial Officer at Lucy Therapeutics

Chief Financial Officer Bryan is a financial executive with over 25 years of experience managing biotechnology companies from the start-up phase through periods of rapid growth into complex publicly traded entities. He is experienced in building systems and infrastructure, successful at fundraising, and was instrumental in three successful IPOs. Bryan has served in senior roles at CombinatoRx, Synta Pharmaceuticals, Shionogi Bioresearch, and held management roles at Genzyme Corporation and Hybritech.

Timeline

  • Chief Financial Officer

    Current role

View in org chart